» Articles » PMID: 33763076

Recent Developments in Clinical Applications of Mesenchymal Stem Cells in the Treatment of Rheumatoid Arthritis and Osteoarthritis

Overview
Journal Front Immunol
Date 2021 Mar 25
PMID 33763076
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cell (MSC) therapies have been used as cell-based treatments for decades, owing to their anti-inflammatory, immunomodulatory, and regenerative properties. With high expectations, many ongoing clinical trials are investigating the safety and efficacy of MSC therapies to treat arthritic diseases. Studies on osteoarthritis (OA) have shown positive clinical outcomes, with improved joint function, pain level, and quality of life. In addition, few clinical MSC trials conducted on rheumatoid arthritis (RA) patients have also displayed some optimistic outlook. The largely positive outcomes in clinical trials without severe side effects establish MSCs as promising tools for arthritis treatment. However, further research is required to investigate its applicability in clinical settings. This review discusses the most recent advances in clinical studies on MSC therapies for OA and RA.

Citing Articles

Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials.

Zeng L, Liu C, Wu Y, Liu S, Zheng Y, Hao W Stem Cell Res Ther. 2025; 16(1):65.

PMID: 39934871 PMC: 11817852. DOI: 10.1186/s13287-025-04184-x.


Establishment of iPSC-Derived MSCs Expressing hsa-miR-4662a-5p for Enhanced Immune Modulation in Graft-Versus-Host Disease (GVHD).

Lee S, Kim E, Lee H, Lim S, Jung C, Kang Y Int J Mol Sci. 2025; 26(2).

PMID: 39859561 PMC: 11766046. DOI: 10.3390/ijms26020847.


Innovative Biotherapies and Nanotechnology in Osteoarthritis: Advancements in Inflammation Control and Cartilage Regeneration.

Liu B, Liu T, Li Y, Tan C Int J Mol Sci. 2025; 25(24.

PMID: 39769149 PMC: 11677281. DOI: 10.3390/ijms252413384.


Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Loaded Mir-29-3p Targets AhR to Improve Juvenile Idiopathic Arthritis via Inhibiting the Expression of IL-22 in CD4 T Cell.

Wei X, Sui K, Peng Y, Li S, Fang Y, Chen Z Stem Cell Rev Rep. 2024; 21(2):536-553.

PMID: 39621151 DOI: 10.1007/s12015-024-10827-y.


Navigating stem cell culture: insights, techniques, challenges, and prospects.

Gorska A, Trubalski M, Borowski B, Brachet A, Szymanczyk S, Markiewicz R Front Cell Dev Biol. 2024; 12:1435461.

PMID: 39588275 PMC: 11586186. DOI: 10.3389/fcell.2024.1435461.


References
1.
Berenbaum F . Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2012; 21(1):16-21. DOI: 10.1016/j.joca.2012.11.012. View

2.
Guo Q, Wang Y, Xu D, Nossent J, Pavlos N, Xu J . Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018; 6:15. PMC: 5920070. DOI: 10.1038/s41413-018-0016-9. View

3.
Gronthos S, Brahim J, Li W, Fisher L, Cherman N, Boyde A . Stem cell properties of human dental pulp stem cells. J Dent Res. 2002; 81(8):531-5. DOI: 10.1177/154405910208100806. View

4.
Silman A, Pearson J . Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 2002; 4 Suppl 3:S265-72. PMC: 3240153. DOI: 10.1186/ar578. View

5.
Erices A, Conget P, Minguell J . Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109(1):235-42. DOI: 10.1046/j.1365-2141.2000.01986.x. View